CVS Health Corp (CVS) fell 3.4% after the company's plan to split into two independent publicly traded entities weighed on investor sentiment. The move is supported by pronounced technical ...
CVS Health (CVS) stock is trading at $85.21, reflecting a daily decline of 3.83%. The share price is positioned below its key moving averages, indicating broad seller ...
Employers and other health plan sponsors could break even on GLP-1 medicines if monthly prices fall below $350, as lower use of hospital and emergency services offsets more of the drug bill. CVS ...
CVS is splitting its retail pharmacy business from its much larger health insurance arm after years of expansion across the U.S. healthcare chain. The move highlights mounting pressure on ...
CVS Health Corp (CVS) climbed 2.67% after the company announced plans to separate its retail pharmacy business from its insurance and pharmacy services operations, alongside better-than-expected ...
CVS plans to divide its $117 billion empire into several entities by 2028. This may affect 9,000 pharmacies as well as such brands as Aetna and Caremark. The decision is a response to ...
CVS Health is moving toward a two-company separation that prompts fresh scrutiny of key insurance ratings across its Aetna operations. The review covers Aetna Health & Life Group entities and CVS ...
Political and legal pressure on vertically integrated healthcare groups is pushing CVS Health to consider a split of its retail pharmacy operations from its insurance and pharmacy benefits ...
Healthcare stocks are extending a strong run as investors rotate toward defensive sectors in volatile markets. CVS Health is emerging as a technical candidate for a longer-term advance, with ...
With energy prices and interest rates pressuring the economic outlook, investors are reassessing how long the artificial intelligence-driven equity rally can keep supporting broader market gains. ...
Federal authorities are resolving a long-running case over how CVS handled opioid and other controlled-substance prescriptions across its pharmacy operations. The agreement covers alleged conduct ...
Humana gains sharply in premarket trading after new U.S. Medicare star ratings position the insurer well for 2027 bonus payments and enrollment momentum. The company says 95% of its Medicare ...
CVS Health Corp (CVS) climbed 3.58% after a federal judge allowed a lawsuit over revenue inflation claims involving artificial intelligence to proceed, bringing renewed attention to ongoing legal ...
Cardinal Health gains on Thursday after extending a key distribution relationship with CVS Health, easing a major uncertainty for investors as markets navigate higher Treasury yields and shifting ...
Veterinary services provider CVS Group reports higher revenue and earnings for the year ended 30 June 2026, supported by like-for-like sales growth and a larger Australian business. The company ...
Luxury groups are using Milan and Paris Fashion Week to defend demand as weaker spending and geopolitical tensions cloud the outlook for high-end goods. Investors are watching whether costly ...
Investors are weighing a mixed set of corporate updates on Thursday as earnings reactions pressure parts of the technology sector and a large block of SpaceX shares becomes eligible to trade. The ...
CVS Health is lifting its annual profit outlook after a stronger second quarter supports its pharmacy and insurance operations. The upgrade comes as the company posts another earnings beat, ...
CVS Health's Caremark reaches a settlement with the U.S. Federal Trade Commission that targets rebate practices in the pharmacy benefits market. The agreement also requires the company to count ...
Rising medical costs and weaker enrollment are pushing insurers selling Affordable Care Act coverage to pursue sharply higher prices for next year. The requested 14% median premium increase over ...
U.S. equity investors are heading into Friday with attention on fresh stock-specific momentum and a key consumer sentiment release after the Nasdaq Composite posts a fourth straight daily decline. ...